At the metabolic level, the observed increased availability of IRS2, IGFBP2 and, to a lower extent, IRS1 after treatment suggested an elevated sensitivity to insulin in VAT under hypercortisolemia. This evidence concerns the gene IGFBP2 and adrenal gland hyperfunction.